BC Biomedical Laboratories Adult Reference Ranges

Transcription

1 BC Biomedical Laboratories Adult s Name Age 25 OH VITAMIN D Blood B nmol/l Interpretation: < 25 Deficient Insufficient Sufficient > 200 Toxic 5HIAA (CALC) Urine B <= 49 umol/d Based on a 24 hour urine collection. ALANINE AMINOTRANSFERASE Blood F <= 35 U/L ALANINE AMINOTRANSFERASE Blood M <= 49 U/L ALBUMIN - SERUM Blood B g/l ALBUMIN/CREAT RATIO-URINE Urine F <= 2.7 mg/mmol Creat. ALBUMIN/CREAT RATIO-URINE Urine M <= 1.9 mg/mmol Creat. ALBUMIN-URINE (CALC) Urine B <= 29 mg/specim en ALKALINE PHOSPHATASE Blood F U/L ALKALINE PHOSPHATASE Blood F U/L ALKALINE PHOSPHATASE Blood M U/L ALKALINE PHOSPHATASE Blood M U/L ALPHA - FETOPROTEIN Blood F 0-44 <= 7 ug/l ALPHA - FETOPROTEIN Blood F <= 7 ug/l ALPHA - FETOPROTEIN Blood M <= 7 ug/l AMYLASE-SERUM Blood B <= 99 U/L ANTI-MITOCHONDRIAL ABS. Blood B Negative ANTINUCLEAR ANTIBODIES Blood B Negative APOLIPOPROTEIN B Blood B g/l APOLIPOPROTEIN B Blood B g/l AST (SGOT) Blood B <= 35 U/L BASOPHILS Blood B <= *9/L BASOPHILS Blood B <= *9/L BICARBONATE Blood B mmol/l BILIRUBIN Urine B Negative BILIRUBIN - TOTAL Blood B <= 24 umol/l Based on a 24 hour urine collection. ANTI-THYROID PEROXIDASE Blood B <= 34 ku/l Generally, thyroid autoimmune disorders are associated with values of 35 ku/l or greater. However, approximately 20% of the normal population may exhibit values between 35 ku/l and 300 ku/l. B12 Blood B pmol/l Interpretation: Serum B12 [Probability of symptomatic deficiency] < 75 pmol/l high pmol/l moderate pmol/l low >220 pmol/l rare. Clinically significant B12 deficiency may occur with B12 levels in the normal range, particularly in the elderly. ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 1 / 7

2 BC Biomedical Laboratories Adult s Age BILIRUBIN-DIRECT Blood B <= 6 umol/l BLOOD Urine B Negative C REACTIVE PROTEIN Blood B mg/l C3 Blood B g/l C4 Blood B g/l CA 125 Blood B <= 34 ku/l CA 15-3 Blood B <= 27 ku/l CA 19-9 Blood B <= 36 ku/l CALCIUM - SERUM Blood B mmol/l CALCIUM-URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. CARBAMAZEPINE Blood B umol/l Therapeutic ranges are based on trough level monitoring. CAROTENE Blood B umol/l CERULOPLASMIN Blood B g/l CHLORIDE - SERUM Blood B mmol/l CHLORIDE-URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. CHLORIDE-URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. CHOLESTEROL Blood B mmol/l CHOLESTEROL Blood B mmol/l CHOLESTEROL Blood B mmol/l CITRATE (CALC) Urine B mmol/d Based on a 24 hour urine collection. CLOZAPINE Blood B nmol/l CORTISOL - AM Blood B nmol/l CORTISOL - PM Blood B nmol/l 50-70% of AM Cortisol CORTISOL-URINARY-FREE Urine B 0-17 nmol/d CORTISOL-URINARY-FREE Urine F nmol/d CORTISOL-URINARY-FREE Urine M nmol/d CPK Blood F <= 139 U/L CPK Blood M <= 164 U/L CREATININE - SERUM Blood F umol/l CREATININE - SERUM Blood M umol/l CREATININE-URINE (CALC) Urine F mmol/d Based on a 24 hour urine collection. CREATININE-URINE (CALC) Urine M mmol/d Based on a 24 hour urine collection. D-DIMER Blood B <= 499 ugfeu/l DHEA - SULFATE Blood F umol/l DHEA - SULFATE Blood F umol/l DHEA - SULFATE Blood F <= 3 umol/l DHEA - SULFATE Blood M umol/l DHEA - SULFATE Blood M umol/l DHEA - SULFATE Blood M umol/l DHEA - SULFATE Blood M <= 2 umol/l DIGOXIN Blood B nmol/l ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 2 / 7

3 BC Biomedical Laboratories Adult s Age DOPAMINE (CALC) Urine B nmol/d Based on a 24 hour urine collection. EOSINOPHILS Blood B <= *9/L EOSINOPHILS Blood B <= *9/L EPINEPHRINE (CALC) Urine B <= 89 nmol/d Based on a 24 hour urine collection. EPITHELIAL CELL Urine B Negative ESTRADIOL Blood F pmol/l (Less than 130) Prepubertal (Less than 607) Follicular ( ) Midcycle ( ) Luteal (Less than 202) Postmenopausal ESTRADIOL Blood F pmol/l (Less than 130) Prepubertal (Less than 607) Follicular ( ) Midcycle ( ) Luteal (Less than 202) Postmenopausal ESTRADIOL Blood M <= 223 pmol/l ESTRADIOL Blood M <= 223 pmol/l FERRITIN Blood B 0-18 >= 12 ug/l FERRITIN Blood B >= 15 ug/l Interpretation: < 15 ug/l - diagnostic of iron deficiency ug/l - probable iron deficiency ug/l - possible iron deficiency > 100 ug/l- iron deficiency unlikely FSH Blood F <= 133 U/L Follicular ( ) Midcycle ( ) Luteal ( ) Postmenopausal ( ) FSH Blood M U/L FSH Blood M U/L GGT Blood F <= 30 U/L GGT Blood M <= 48 U/L GLOMERULAR FILTRATION RT Blood B >= 60 ml/min/1. 73sq.m GLUCOSE Urine B Negative FIBRINOGEN Blood B g/l Non- pregnant FIBRINOGEN Blood F g/l Pregnant FREE - T4 Blood B pmol/l FREE T3 Blood B pmol/l FREE T3 Blood B pmol/l GLOMERULAR FILTRATION RT Blood B 0-18 ml/min/1. 73sq.m GLUCOSE-2HR PC (SERUM) Blood B mmol/l GLUCOSE-2HR PC (SERUM) Blood B mmol/l GLUCOSE-FASTING (SERUM) Blood B mmol/l GLUCOSE-FASTING (SERUM) Blood B mmol/l GLUCOSE-RANDOM (SERUM) Blood B mmol/l GLUCOSE-RANDOM (SERUM) Blood B mmol/l Not reported on patients under 19 years ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 3 / 7

4 BC Biomedical Laboratories Adult s Age GRANS IMMATURE Blood B <= *9/L HEMATOCRIT Blood F L/L HEMATOCRIT Blood F L/L HEMATOCRIT Blood M L/L HEMATOCRIT Blood M L/L HEMOGLOBIN Blood F g/l HEMOGLOBIN Blood F g/l HEMOGLOBIN Blood M g/l HEMOGLOBIN Blood M g/l HGB A1C Blood B % Result assumes normal red cell lifespan and absence of hemoglobinopathy. HbA1C values are now reported as a percentage, as per BCMA/MSP Guidelines "Diabetic Care" HIGH DENSITY LIPOPROTEIN Blood F >= 1.2 mmol/l HIGH DENSITY LIPOPROTEIN Blood F 2-17 >= 1.1 mmol/l HIGH DENSITY LIPOPROTEIN Blood M >= 1 mmol/l HIGH DENSITY LIPOPROTEIN Blood M 2-17 >= 1.1 mmol/l HVA (CALC) Urine B <= 40 umol/d Based on a 24 hour urine collection. HVA (CALC) Urine B umol/d Based on a 24 hour urine collection. IGE Blood B <= 239 ug/l IMMUNOGLOBULIN A Blood B g/l IMMUNOGLOBULIN G Blood B g/l IMMUNOGLOBULIN M Blood B g/l INR Blood B Recommended Warfarin Therapeutic s ( ) Most Indications ( or higher) Most mechanical heart valves; Thromboembolism when INR already ; some patients with antiphospholipid antibody syndrome. INTACT & BETA HCG Blood F U/L Time after LMP Expected 3rd week (6-71) 4th week (10-750) 5th week ( ) 6th week ( ) 7th week ( ) 8th&9th week ( ) 10th week ( ) 12th week ( ) 14th week ( ) 15th week ( ) 16th week ( ) 17th&18th week ( ) Non-Preg (Less than 10) INTACT & BETA HCG Blood M <= 9 U/L IRON BINDING CAP.(TIBC) Blood B umol/l IRON SATURATION Blood B IRON-TOTAL Blood B umol/l KETONES Urine B Negative ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 4 / 7

5 BC Biomedical Laboratories Adult s Age LACTATE DEHYDROGENASE Blood B <= 219 U/L LEUKOCYTES Urine B Negative LH Blood F <= 73 U/L Follicular ( ) Midcycle ( ) Luteal ( ) Postmenopausal ( ) LH Blood M U/L LH Blood M U/L LIPASE Blood B <= 74 U/L LITHIUM Blood B mmol/l (Target range for acute therapy is ) Therapeutic ranges are based on trough level monitoring. LITHIUM Blood B mmol/l (Target range for acute therapy is ) Therapeutic ranges are based on trough level monitoring. LOW DENSITY LIPOPROTEIN Blood B mmol/l The LDL cholesterol therapeutic target for intermediate and high risk individuals is <=2.00 mmol/l. If triglycerides are >=1.50 mmol/l, consider using alternate primary target non-hdl cholesterol or apob as treatment goal. For low risk individuals with LDL cholesterol >=5.00 mmol/l, the target is reduction of LDL cholesterol by >=50 percent, See Can J Cardiol 2013 vol 29 pages 151 to 167. LOW DENSITY LIPOPROTEIN Blood B mmol/l The LDL cholesterol therapeutic target for intermediate and high risk individuals is <=2.00 mmol/l. If triglycerides are >=1.50 mmol/l, consider using alternate primary target non-hdl cholesterol or apob as treatment goal. For low risk individuals with LDL cholesterol >=5.00 mmol/l, the target is reduction of LDL cholesterol by >=50 percent, See Can J Cardiol 2013 vol 29 pages 151 to 167. LOW DENSITY LIPOPROTEIN Blood B mmol/l The LDL cholesterol therapeutic target for intermediate and high risk individuals is <=2.00 mmol/l. If triglycerides are >=1.50 mmol/l, consider using alternate primary target non-hdl cholesterol or apob as treatment goal. For low risk individuals with LDL cholesterol >=5.00 mmol/l, the target is reduction of LDL cholesterol by >=50 percent, See Can J Cardiol 2013 vol 29 pages 151 to 167. LYMPHOCYTES Blood B *9/L LYMPHOCYTES Blood B *9/L MAGNESIUM - SERUM Blood B mmol/l MCH Blood F pg MCH Blood F pg MCH Blood M pg MCH Blood M pg ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 5 / 7

6 BC Biomedical Laboratories Adult s Age MCHC Blood F g/l MCHC Blood F g/l MCHC Blood M g/l MCHC Blood M g/l MCV Blood B fl MCV Blood B fl METANEPHRN.FREE(CALC) Urine B <= umol/d MONOCYTES Blood B <= *9/L MONOCYTES Blood B <= *9/L NEUTROPHILS Blood B *9/L NEUTROPHILS Blood B *9/L NITRITE Urine B Negative NON-HDL CHOLESTEROL Blood B mmol/l Non HDL-cholesterol is calculated from total cholesterol and HDL-C and is not affected by the fasting status of the patient. The optimal non HDLcholesterol level for intermediate and high risk individuals is = 2.60 mmol/l. See Can J Cardiol 2013 vol 29 pgs 151 to 167. NOREPINEPHRINE (CALC) Urine B <= 649 nmol/d Based on a 24 hour urine collection. NORMETANEPH.FREE(CALC) Urine B <= umol/d OXALATE (CALC) Urine F umol/d Based on a 24 hour urine collection. OXALATE (CALC) Urine M umol/d Based on a 24 hour urine collection. PATHOLOGICAL CASTS Urine B Negative PH Urine B PHENYTOIN Blood B umol/l Therapeutic ranges are based on trough level monitoring. PHOSPHORUS - SERUM Blood B mmol/l PHOSPHORUS - URINE (CALC) Urine B <= 31 mmol/d Based on a 24 hour urine collection. PLATELET COUNT Blood B *9/L PLATELET COUNT Blood B *9/L POTASSIUM - SERUM Blood B mmol/l POTASSIUM - URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. PROGESTERONE Blood B nmol/l PROLACTIN Blood F ug/l PROLACTIN Blood F ug/l PROLACTIN Blood M ug/l PROTEIN (SULPHOSAL) Urine B Negative PROTEIN-URINE (CALC) Urine B <= 0.14 g/d Based on a 24 hour urine collection. PSA Blood F ug/l PSA Blood M <= 4 ug/l PTT Blood B sec RBC Urine B / HPF ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 6 / 7

7 BC Biomedical Laboratories Adult s Age RBC COUNT Blood F *12/L RBC COUNT Blood F *12/L RBC COUNT Blood M *12/L RBC COUNT Blood M *12/L RETICULOCYTES Blood B *9/L RETICULOCYTES Blood B *9/L RHEUMATOID FACTOR Blood B <= 9 ku/l SED RATE Blood B mm/hr SHBG Blood F nmol/l SHBG Blood M nmol/l SODIUM - SERUM Blood B mmol/l SODIUM - URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. SPECIFIC GRAV DIPSTICK Urine B TESTO-BIO AVAIL (CALC) Blood F <= 0.9 nmol/l Method of Vermeulen TESTO-BIO AVAIL (CALC) Blood M nmol/l TESTO-BIO AVAIL (CALC) Blood M nmol/l Method of Vermeulen TESTOSTERONE Blood F nmol/l TESTOSTERONE Blood F nmol/l TESTOSTERONE Blood M nmol/l TESTOSTERONE Blood M nmol/l TESTOSTERONE-FREE (CALC) Blood F <= 69 pmol/l Method of Vermeulen TESTOSTERONE-FREE (CALC) Blood F <= 24 pmol/l Method of Vermeulen TESTOSTERONE-FREE (CALC) Blood M pmol/l Method of Vermeulen TOTAL PROTEIN - SERUM Blood B g/l TRIGLYCERIDES Blood B <= 2.2 mmol/l TRIGLYCERIDES Blood B 2-17 <= 1.2 mmol/l TROPONIN I Blood B <= 0.05 ug/l TSH Blood B mu/l UREA Blood B mmol/l UREA-URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. URIC ACID - SERUM Blood F umol/l URIC ACID - SERUM Blood M umol/l URIC ACID-URINE (CALC) Urine B mmol/d Based on a 24 hour urine collection. UROBILINOGEN Urine B Negative VALPROIC ACID Blood B umol/l Therapeutic ranges are based on trough level monitoring. VMA (CALC) Urine B <= 30 umol/d Based on a 24 hour urine collection. VMA (CALC) Urine B <= 37 umol/d Based on a 24 hour urine collection. WBC Urine B / HPF WBC - CORRECTED Blood B *9/L WBC - CORRECTED Blood B *9/L ZINC Blood B ranges appear on individual reports and are based on methods and technology in use on that day. s accompanying the Page: 7 / 7